Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Combining Weak Chemical Forces to Strengthen a Novel Imaging Technology

Published: Thursday, May 22, 2014
Last Updated: Thursday, May 22, 2014
Bookmark and Share
Illinois researchers turn current contrast agent technology on its head—or rather, they turn it inside out.

When Associate Professor of Chemical and Biomolecular Engineering Hyunjoon Kong, graduate student Cartney Smith, and colleagues set out to improve MR imaging (MRI), they turned current contrast agent technology on its head—or rather, they turned it inside out.  The new compound they designed in collaboration with Roger Adams Professor of Chemistry Steven C. Zimmerman is not only more effective, but also self-assembling. Kong is a member of the Regenerative Biology and Tissue Engineering research theme at the Institute for Genomic Biology.

When doctors perform an MRI, they administer a contrast agent: a chemical that, when injected into the bloodstream or ingested by the patient just before the MRI, improves the clarity of structures or organs in the resulting image.  One common class of contrast agent, often used for imaging of blood vessels and internal bleeding, contains gadolinium, a rare-earth metal.

Recently, biomedical researchers have found ways to increase the effectiveness of certain contrast agents by associating them with nanoparticles.  The contrast agent being used is packaged inside or bonded to the surface of microscopic particles, which can be designed to target certain regions of the body or prolong the agent’s activity.

Researchers are now exploring the multipurpose use of nanoparticles.  If particles could be loaded with several types of contrast agents or dyes instead of one, or a contrast agent along with another type of diagnostic aid or a medication, doctors could more efficiently test for and treat conditions, and limit the number of injections received by patients.

Just like toddlers sharing a new toy, though, compounds packaged together into a nanoparticle cannot always play well together.  For example, contrast agents may bind to other chemicals, reducing their effectiveness.  In addition, when contrast agents are enclosed inside a nanoparticle, they may not work as well.  Attempts to attach agents to the outer surface of nanoparticles via covalent formation are also problematic, as they can negatively affect the activity of the nanoparticles or the compounds that they carry.

Kong, Smith and colleagues tackled these challenges by using interactions between naturally occurring biomolecules as a guide.  Many types of proteins are strongly attached to cell membranes not by covalent bonds, but by the sum of multiple weaker forces—the attraction of positive and negative charges, and the tendency of non-polar (oil-like) substances to seek each other and avoid water.

The group hypothesized that the same types of forces could be used to attach a contrast agent to the surface of a type of nanoparticle called a liposome, which resembles a little piece of cell membrane in the shape of a tiny bubble.  The researchers designed a “fastener” molecule, DTPA-chitosan-g-C18, that is charged, attracting it to the liposome and binding it to the contrast agent gadolinium. A nonpolar region anchors it to the liposome membrane.

In a series of experiments reported in a recent ACS Nano article (DOI: 10.1021/nn4026228), Kong and others demonstrated that their fastener molecule readily inserted itself into the membrane of pre-made liposomes.  Gadolinium stably associated with the modified nanoparticles in solution, and experiments in animal models showed that these nanoparticles produced clear diagnostic images.

“The strategy works like Velcro on a molecular level to adhere functional units to the outer leaflet of a liposome,” said Smith, who was first author on the study.  “This work represents a new material design strategy that is scalable and easily implemented.  The development of improved contrast agents has the potential to directly impact patients' lives by detecting damaged blood vessels.”

One of the difficulties of working with liposomes is their tendency to degrade inside the body.  When the fastener-loaded liposomes degraded, some of the efficacy of the gadolinium was lost.  In a second study published in Langmuir (DOI: 10.1021/la500412r), Kong and Smith developed a process for chemically cross-linking the components of the nanoparticle that prolonged the life of the nanoparticles in biological conditions.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genome Mining Effort Discovers 19 New Natural Products in Four Years
Each of these products is a potential new drug. One of them has already been identified as an antibiotic.
Friday, September 11, 2015
Research Conducted on Ion Channels
Researchers see subtle differences between two branches of an important family of neurotransmitter-gated ion channels by using a high-resolution single-molecule study technique.
Thursday, July 28, 2011
Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos